Detalhe da pesquisa
1.
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial.
Lancet
; 403(10436): 1543-1553, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604209
2.
Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease.
J Am Coll Cardiol
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38759906